ProShare Advisors
APGE icon

ProShare Advisors’s Apogee Therapeutics APGE Stock Holding History

ProShare Advisors’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Sell
8,886
-578
-6% -$42K ﹤0.01% 886
2025
Q4 		$714K Buy
9,464
+2,221
+31% +$140K ﹤0.01% 946
2025
Q3 		$288K Sell
7,243
-1,022
-12% -$39K ﹤0.01% 1460
2025
Q2 		$359K Sell
8,265
-1,970
-19% -$74.9K ﹤0.01% 1324
2025
Q1 		$382K Sell
10,235
-2,570
-20% -$99.4K ﹤0.01% 1245
2024
Q4 		$580K Buy
12,805
+2,985
+30% +$152K ﹤0.01% 1185
2024
Q3 		$577K Buy
9,820
+1,504
+18% +$72.1K ﹤0.01% 1062
2024
Q2 		$327K Sell
8,316
-1,722
-17% -$83.6K ﹤0.01% 1227
2024
Q1 		$667K Buy
+10,038
New +$438K ﹤0.01% 932

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return